Link to original article in PubMed
Amyotrophic Lateral Sclerosis like Syndrome Following Subcutaneous Administration of Manganese12/2/2020 A new cast report out of Sweden by Roos and colleagues 2020 suggests that subcutaneous exposure to manganese may be associated with a rapidly progressing form of ALS. This case report is about a 56 year old man who developed ALS in close chronological relationship to his exposure to manganese that was administered as a traditional Kenyan medical practice call Ogosaraka via cuts in the skin of his back near his spinal cord. Within four months the man began to develop neurological symptoms which included symmetrical muscle weakness in his legs, arms, and neck. Neurophysiological testing revealed fibrillation potentials indicative of denervation. The patient died from respiratory failure 10 months post exposure. Although the results of neuroimaging studies showing manganese accumulation n brain nor of post-mortem neuropathological studies confirming the involvement of upper motor neurons in this case were not provided by the authors, this rapidly progressing case of unusual manganese neurotoxicity nevertheless raises concerns about potential risks for interactions between traditional medicine and the onset and progression of latent ALS in vulnerable individuals.
Link to original article in PubMed
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
AuthorDr. Marcia Ratner shares and reviews the news. Archives
February 2023
Categories |